This finding underscores the critical role of FEN1 as a gene associated with poor prognosis and sensitivity to cisplatin in NB, suggesting its potential as a target for therapeutic intervention and further studies into its mechanisms of action in NB. Here, FEN1 is linked to neuroblastoma.